recombinant human superoxide dismutase

also known as Kang Fu Pen · rhSOD

Investigated by: Affiliated Cancer Hospital of Guizhou Medical University · Cancer Institute and Hospital, Chinese Academy of Medical Sciences · Chinese PLA General Hospital · Fudan University · Henan Cancer Hospital · Jiangsu Cancer Institute & Hospital
+10 more
· Jilin Provincial Tumor Hospital · Peking Union Medical College Hospital · Peking University Cancer Hospital & Institute · Peking University Third Hospital · Shandong Cancer Hospital and Institute · Sichuan Cancer Hospital and Research Institute · Sun Yat-sen University · The First Affiliated Hospital of Air Force Medicial University · Xiangya Hospital of Central South University · Zhejiang Cancer Hospital

today NCT04819685 · Ph 4

202120222023202420252026

Phase	Registry id	Dates	Indication	Sponsor	Status	Outcome
Phase 4	NCT04819685	Mar 2021 → Mar 2023	cervical cancer	Peking Union Medical College Hospital	Unknown	No outcome recorded

Every value below carries the sentence it was read from. 2 sources stand behind the page.

Field	Value	Cited text
Known as	recombinant human superoxide dismutase	“The purpose of this study was to evaluate the efficacy of recombinant human superoxide dismutase (rhSOD) enemas in radiation-induced acute rectal injury (RARI) in patients with...” PMID 38705489 ↗ May 2024
Known as	Kang Fu Pen	“Kang Fu Pen (recombinant human superoxide dismutase) retention enema, 50ml/ time, once every other day.” NCT04819685 ↗
Known as	rhSOD	“recombinant human superoxide dismutase (rhSOD) enemas in radiation-induced acute rectal injury (RARI)” PMID 38705489 ↗ May 2024
Modality	Protein / enzyme biologic	“recombinant human superoxide dismutase” NCT04819685 ↗
Route	Other	“retention enema” NCT04819685 ↗